Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J H Rex

Showing results (61-70 of 106) with videos related to

Pageof 11
Sort By:
The Journal of Infectious Diseases|August 1, 1994
Correlation between in vitro and in vivo activity of antifungal agents against Candida speciesE J Anaissie, N C Karyotakis, R Hachem, et al.
Antimicrobial Agents and Chemotherapy|March 20, 2019
Efficacy of Olorofim (F901318) against <i>Aspergillus fumigatus</i>, <i>A. nidulans</i>, and <i>A. tanneri</i> in Murine Models of Profound Neutropenia and Chronic Granulomatous DiseaseS Seyedmousavi, Y C Chang, D Law, et al.
The Journal of Infectious Diseases|December 12, 1997
Aspergillus fumigatus conidia induce a Th1-type cytokine responseM L Grazziutti, J H Rex, R E Cowart, et al.
Transfusion|July 1, 1995
Protection of human polymorphonuclear leukocyte function from the deleterious effects of isolation, irradiation, and storage by interferon-gamma and granulocyte-colony-stimulating factorJ H Rex, S C Bhalla, D M Cohen, et al.
Clinical and Laboratory Haematology|March 1, 1997
Effects of in vitro and in vivo cytokine treatment, leucapheresis and irradiation on the function of human neutrophils: implications for white blood cell transfusion therapyD M Cohen, S C Bhalla, E J Anaissie, et al.
Antimicrobial Agents and Chemotherapy|February 4, 1998
Optimizing the correlation between results of testing in vitro and therapeutic outcome in vivo for fluconazole by testing critical isolates in a murine model of invasive candidiasisJ H Rex, P W Nelson, V L Paetznick, et al.
The Journal of Infectious Diseases|April 1, 1991
In vivo interferon-gamma therapy augments the in vitro ability of chronic granulomatous disease neutrophils to damage Aspergillus hyphaeJ H Rex, J E Bennett, J I Gallin, et al.
Journal of Clinical Microbiology|July 1, 1994
Selection of candidate quality control isolates and tentative quality control ranges for in vitro susceptibility testing of yeast isolates by National Committee for Clinical Laboratory Standards proposed standard methodsM A Pfaller, M Bale, B Buschelman, et al.
Medical Mycology|February 24, 2001
Deep Candida infections in the neutropenic and non-neutropenic host: an ISHAM symposiumI N Tiraboschi, J E Bennett, C A Kauffman, et al.
Medical Mycology|February 24, 2001
Mycoses in AIDSB Dupont, H H Crewe Brown, K Westermann, et al.
Pageof 11

Showing results (61-70 of 106) with videos related to

Sort By:
Pageof 11
The Journal of Infectious Diseases|August 1, 1994
Correlation between in vitro and in vivo activity of antifungal agents against Candida speciesE J Anaissie, N C Karyotakis, R Hachem, et al.
Antimicrobial Agents and Chemotherapy|March 20, 2019
Efficacy of Olorofim (F901318) against <i>Aspergillus fumigatus</i>, <i>A. nidulans</i>, and <i>A. tanneri</i> in Murine Models of Profound Neutropenia and Chronic Granulomatous DiseaseS Seyedmousavi, Y C Chang, D Law, et al.
The Journal of Infectious Diseases|December 12, 1997
Aspergillus fumigatus conidia induce a Th1-type cytokine responseM L Grazziutti, J H Rex, R E Cowart, et al.
Transfusion|July 1, 1995
Protection of human polymorphonuclear leukocyte function from the deleterious effects of isolation, irradiation, and storage by interferon-gamma and granulocyte-colony-stimulating factorJ H Rex, S C Bhalla, D M Cohen, et al.
Clinical and Laboratory Haematology|March 1, 1997
Effects of in vitro and in vivo cytokine treatment, leucapheresis and irradiation on the function of human neutrophils: implications for white blood cell transfusion therapyD M Cohen, S C Bhalla, E J Anaissie, et al.
Antimicrobial Agents and Chemotherapy|February 4, 1998
Optimizing the correlation between results of testing in vitro and therapeutic outcome in vivo for fluconazole by testing critical isolates in a murine model of invasive candidiasisJ H Rex, P W Nelson, V L Paetznick, et al.
The Journal of Infectious Diseases|April 1, 1991
In vivo interferon-gamma therapy augments the in vitro ability of chronic granulomatous disease neutrophils to damage Aspergillus hyphaeJ H Rex, J E Bennett, J I Gallin, et al.
Journal of Clinical Microbiology|July 1, 1994
Selection of candidate quality control isolates and tentative quality control ranges for in vitro susceptibility testing of yeast isolates by National Committee for Clinical Laboratory Standards proposed standard methodsM A Pfaller, M Bale, B Buschelman, et al.
Medical Mycology|February 24, 2001
Deep Candida infections in the neutropenic and non-neutropenic host: an ISHAM symposiumI N Tiraboschi, J E Bennett, C A Kauffman, et al.
Medical Mycology|February 24, 2001
Mycoses in AIDSB Dupont, H H Crewe Brown, K Westermann, et al.
Pageof 11